Join
Live feed
·
INSIDERFilingvia Quantisnow
Sutro Biopharma Inc. logo

Chief Executive Officer Chung Jane converted options into 18,750 shares and covered exercise/tax liability with 6,708 shares, increasing direct ownership by 12% to 110,350 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
STRO· Sutro Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track STRO (Sutro Biopharma Inc.) and more on Quantisnow.